KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) EBT (2016 - 2026)

Medtronic's EBT history spans 13 years, with the latest figure at $1.4 billion for Q1 2026.

  • For Q1 2026, EBT fell 8.83% year-over-year to $1.4 billion; the TTM value through Jan 2026 reached $5.6 billion, up 6.51%, while the annual FY2025 figure was $5.6 billion, 16.35% up from the prior year.
  • EBT for Q1 2026 was $1.4 billion at Medtronic, down from $1.6 billion in the prior quarter.
  • Across five years, EBT topped out at $1.6 billion in Q2 2022 and bottomed at $856.0 million in Q2 2024.
  • The 5-year median for EBT is $1.4 billion (2022), against an average of $1.4 billion.
  • The largest annual shift saw EBT plummeted 44.81% in 2024 before it surged 47.31% in 2025.
  • A 5-year view of EBT shows it stood at $1.4 billion in 2022, then dropped by 5.88% to $1.3 billion in 2023, then grew by 18.74% to $1.6 billion in 2024, then increased by 2.37% to $1.6 billion in 2025, then decreased by 12.03% to $1.4 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's EBT are $1.4 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.3 billion (Q3 2025).